MIFH
EPZM

Migdal Insurance & Financial Holdings’s Epizyme, Inc EPZM Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-52,164
Closed -$454K – 691
2021
Q1 		$454K Buy
52,164
+32,372
+164% +$335K ﹤0.01% 331
2020
Q4 		$215K Buy
+19,792
New +$244K ﹤0.01% 308

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Migdal Insurance & Financial Holdings's EPZM Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Epizyme, Inc (EPZM) in Q2 2021, closing a stake of 52,164 shares — an estimated $454K sold.

Migdal Insurance & Financial Holdings first reported a position in EPZM in Q4 2020 and held it in 2 quarters. The position peaked at $454K in Q1 2021. 126 funds tracked by Wall St. Rank hold EPZM as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Epizyme, Inc position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 52,164 Epizyme, Inc shares in Q2 2021, an estimated $454K.
  • Migdal Insurance & Financial Holdings first reported a position in Epizyme, Inc in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Epizyme, Inc position peaked at $454K in Q1 2021.
  • 126 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.